Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

New AstraZeneca, Amgen drug looks strong rival in severe asthma

A new kind of injectable biotech treatment for severe asthma from AstraZeneca and Amgen promises to help a much broader range of patients than existing medicines such as GlaxoSmithKline’s Nucala.

Read More »

Verastem Soars as Blood Cancer Drug Succeeds in Phase III Study

Verastem, Inc.’s experimental blood cancer drug hit its endpoints in a Phase III trial and the news sent shares of company stock up more than 30 percent.

Read More »

Merck & Co. Takes Out Immuno-Oncology Startup in $603 Million Deal

Merck is complementing the company’s immuno-oncology platform and lead PD-1 inhibitor Keytruda with the newly acquired pipeline of a three-year-old German startup.

Read More »

France’s Servier to face trial over Mediator weight-loss drug

Drug maker Servier and the French drug regulator will face trial over weight-loss pill Mediator, believed to have caused at least 500 deaths in one of France’s worst health scandals, the prosecutor’s office said.

Read More »

Roche lung cancer drug Alecensa slashes brain risk in tests

Patients taking Roche’s targeted lung cancer drug Alecensa have a far lower risk of their disease spreading in the brain than those on Pfizer’s Xalkori, new clinical trial data show.

Read More »

Novo Nordisk settles U.S. probe over diabetes drug for nearly $58.7 million

  (Reuters) – Novo Nordisk will pay nearly $58.7 million to resolve claims the drugmaker’s sales staff downplayed the importance of U.S. Food and Drug Administration-mandated warnings about the cancer risks of its diabetes medication Victoza. The U.S. Justice Department said Tuesday’s settlement would resolve claims Novo Nordisk supplied its sales representatives with information to […]

Read More »

GE Healthcare Launches First-Ever Mammography System that Allows Patients to Control their Compression by Remote Control

GE Healthcare announced FDA 510(k) clearance of an industry-first, patient-assisted mammography device that literally puts women in control of their mammograms.

Read More »

U.S. judge invalidates Mallinckrodt patents on respiratory treatment

A federal judge in Delaware invalidated patents held by Mallinckrodt Pharmaceuticals on its Inomax respiratory treatment system.

Read More »

Insmed’s lung drug meets main goal in key study, shares soar

Insmed Inc. said its drug for the treatment of a rare lung disorder met the main goal in a key study, sending its shares soaring in premarket trading.

Read More »

Device maker Teleflex boosts urology business with NeoTract buy

Medical device maker Teleflex Inc. said on Tuesday it would buy privately held NeoTract Inc. to strengthen its portfolio of urology devices in its second billion-dollar deal in the past nine months.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom